Rybrevant Side Effects Center: Detailed Datasheet

• Generic Name: amivantamab-vmjw for injection
• Brand Name: Rybrevant
• Drug Class: How Do Antineoplastic EGFR Inhibitors Work?, MET Tyrosine Kinase Inhibitors

Rybrevant (Amivantamab-vmjw for Injection) side effects drug center

• Related Drugs
  Afinitor Afinitor-Disperz Alecensa Cyramza Imfinzi Keytruda Libtayo Mekinist Mvasi Opdivo Portrazza Tagrisso Tarceva Tecentriq
• Drug Comparison
  Imfinzi vs. Opdivo Imfinzi vs. Tecentriq Keytruda vs. Imfinzi Keytruda vs. Tecentriq Opdivo vs. Yervoy Sutent vs. Opdivo Tecentriq vs. Opdivo Tecentriq vs. Trodelvy

PROFESSIONAL

SIDE EFFECTS

• Overview
• Professional Information

What Is Rybrevant?

Rybrevant (amivantamab-vmjw) is a bispecific EGF receptor-directed and MET receptor-directed antibody indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA- approved test, whose disease has progressed on or after platinum-based chemotherapy.

What Are Side Effects of Rybrevant?

Side effects of Rybrevant include:

• rash,
• infusion related reactions,
• Infection of the skin surrounding the fingernails or toenails,
• musculoskeletal pain,
• shortness of breath,
• nausea,
• fatigue,
• fluid retention (edema),
• inflammation of the mouth and lips,
• cough,
• constipation,